Company / SG&A per Share
Glaukos Corp. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$5.88
FY2025
5-year range
$3.65 / $5.88
FY2021-FY2025
Trend
+10.5%
vs FY2024
Sector context
#74 of 156
Health Care
What the data says
At $5.88, Glaukos Corp.'s sg&a per share ranks #83 of 156 in the Health Care sector. SG&A per Share has increased for 3 consecutive years, from $3.65 in FY2022 to $5.88 in FY2025.
Based on SEC 10-K filings.
5.88 in FY2025 with a 5-year CAGR of +16.4%.
Increased from $3.75 to $5.88 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +17.2%
- 5-Year CAGR
- +16.4%
- 10-Year CAGR
- -
Sector benchmark
#83 of 156 in Health CareTop 53% of 156This company $5.88 Sector average $11421.53
▼
-99.9% below sector average
Key checks
Key Insights
- Glaukos Corp.'s sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 10.5% year-over-year.
- Ranks #74 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.88 | +10.5% |
| FY2024 | $5.32 | +41.6% |
| FY2023 | $3.75 | +2.9% |
| FY2022 | $3.65 | -6.5% |
| FY2021 | $3.90 | +42.1% |
| FY2020 | $2.75 | +3.1% |
| FY2019 | $2.67 | +42.5% |
| FY2018 | $1.87 | +44.4% |
| FY2017 | $1.30 | -35.6% |
| FY2016 | $2.01 | -71.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026